CTOs on the Move

IARP Headquarters

www.iarp.org

 
IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iarp.org
  • 3540 Soquel Ave Ste A
    Santa Cruz, CA USA 95062
  • Phone: 831.464.4892

Executives

Name Title Contact Details

Similar Companies

Dignity Health

We are dedicated to delivering high-quality, affordable health care services in a compassionate environment that meets each patient`s physical, mental and spiritual needs. Upholding the core values of dignity, justice, stewardship, collaboration, and excellence, our healing philosophy serves not just our patients, but our staff, our communities, and our planet. At Dignity Health a family of more than 60,000 caregivers and staff are delivering excellent care to diverse communities across 17 states. Founded in 1986 and headquartered in San Francisco Dignity Health is the fifth largest hospital provider in the nation and the largest hospital system in California. Through teamwork and innovation, faith and compassion, advocacy and action, we endeavor every day to keep you happy, healthy, and whole.

CancerConsultants.com

CancerConsultants.com is a Ketchum, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Water Lens

Water Lens is an innovative company that is revolutionizing the $10B water testing industry. We have developed a system for real-time chemical analysis of water and other fluids, on location, for industries that use large amounts of water (e.g., oil and gas, agriculture, power generation, coal mining, and food processing).

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

HSI

HSI is a Lombard, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.